Lack of awareness: Both patients and healthcare providers may not be fully aware of the latest advancements or guidelines in cancer treatment. Emotional distress: The emotional burden of a cancer diagnosis can lead to hasty decisions driven by fear rather than rational analysis. Commercial influence: Pharmaceutical marketing can sometimes overshadow evidence-based recommendations, leading to choices influenced by commercial interests. Access to care: Limited access to specialized cancer centers can result in suboptimal treatment plans.
